OBJECTIVE: To evaluate whether there are visual and neuropsychological decrements in workers with low exposure to Hg vapor. METHODS: Visual fields, contrast sensitivity, color vision, and neuropsychological functions were measured in 10 workers (32.5 +/- 8.5 years) chronically exposed to Hg vapor (4.3 +/- 2.8 years; urinary Hg concentration 22.3 +/- 9.3 microg/g creatinine). RESULTS: For the worst eyes, we found altered visual field thresholds, lower contrast sensitivity, and color discrimination compared with controls (P <0.05). There were no significant differences between Hg-exposed subjects and controls on neuropsychological tests. Nevertheless, duration of exposure was statistically correlated to verbal memory and depression scores. CONCLUSIONS: Chronic exposure to Hg vapor at currently accepted safety levels was found to be associated with visual losses but not with neuropsychological dysfunctions in the sample of workers studied.
OBJECTIVE: To evaluate whether there are visual and neuropsychological decrements in workers with low exposure to Hg vapor. METHODS: Visual fields, contrast sensitivity, color vision, and neuropsychological functions were measured in 10 workers (32.5 +/- 8.5 years) chronically exposed to Hg vapor (4.3 +/- 2.8 years; urinary Hg concentration 22.3 +/- 9.3 microg/g creatinine). RESULTS: For the worst eyes, we found altered visual field thresholds, lower contrast sensitivity, and color discrimination compared with controls (P <0.05). There were no significant differences between Hg-exposed subjects and controls on neuropsychological tests. Nevertheless, duration of exposure was statistically correlated to verbal memory and depression scores. CONCLUSIONS: Chronic exposure to Hg vapor at currently accepted safety levels was found to be associated with visual losses but not with neuropsychological dysfunctions in the sample of workers studied.
Authors: Paulo Roney Kilpp Goulart; Daniela Maria Oliveira Bonci; Olavo de Faria Galvão; Luiz Carlos de Lima Silveira; Dora Fix Ventura Journal: PLoS One Date: 2013-04-19 Impact factor: 3.240
Authors: C Polevoy; T E Arbuckle; Y Oulhote; B P Lanphear; K A Cockell; G Muckle; D Saint-Amour Journal: Environ Health Date: 2020-02-07 Impact factor: 5.984
Authors: Thiago Leiros Costa; Mirella Telles Salgueiro Barboni; Ana Laura de Araújo Moura; Daniela Maria Oliveira Bonci; Mirella Gualtieri; Luiz Carlos de Lima Silveira; Dora Fix Ventura Journal: PLoS One Date: 2012-08-15 Impact factor: 3.240
Authors: Thiago L Costa; Balázs V Nagy; Mirella T S Barboni; Paulo S Boggio; Dora F Ventura Journal: Front Psychiatry Date: 2012-09-12 Impact factor: 4.157
Authors: Mirella Telles Salgueiro Barboni; Otto Alexander Maneschg; János Németh; Zoltán Zsolt Nagy; Zoltán Vidnyánszky; Éva M Bankó Journal: Invest Ophthalmol Vis Sci Date: 2020-09-01 Impact factor: 4.799
Authors: Xiaojuan Xu; Daniel Weber; Michael J Carvan; Ryan Coppens; Crystal Lamb; Stefan Goetz; Lillian A Schaefer Journal: Neurotoxicology Date: 2012-07-13 Impact factor: 4.294